Risk Factors for Poor Outcomes Among Patients with Extensively Drug-Resistant Tuberculosis (XDR-TB): A Scoping Review

被引:9
作者
Varshney, Karan [1 ]
Anaele, Beverly [1 ]
Molaei, Matthew [1 ]
Frasso, Rosemary [1 ]
Maio, Vittorio [1 ]
机构
[1] Thomas Jefferson Univ, Coll Populat Hlth, 901 Walnut St,10th Floor, Philadelphia, PA 19107 USA
关键词
drug-resistant; tuberculosis; risk factors; compliance; adherence; XDR-TB; MULTIDRUG-RESISTANT; HIV; TRANSMISSION; EPIDEMIOLOGY; PREVALENCE; MANAGEMENT; EMERGENCE; MORTALITY; STRAINS; CARE;
D O I
10.2147/IDR.S339972
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In recent years, there has been an upsurge in cases of drug-resistant TB, and strains of TB resistant to all forms of treatment have begun to emerge; the highest level of resistance is classified as extensively drug-resistant tuberculosis (XDR-TB). There is an urgent need to prevent poor outcomes (death/default/failed treatment) of XDR-TB, and knowing the risk factors can inform such efforts. The objective of this scoping review was to therefore identify risk factors for poor outcomes among XDR-TB patients. We searched three scientific databases, PubMed, Scopus, and ProQuest, and identified 25 articles that examined relevant risk factors. Across the included studies, the proportion of patients with poor outcomes ranged from 8.6 to 88.7%. We found that the most commonly reported risk factor for patients with XDR-TB developing poor outcomes was having a history of TB. Other risk factors were human immunodeficiency virus (HIV), a history of incarceration, low body mass, being a smoker, alcohol use, unemployment, being male, and being middle-aged. Knowledge and understanding of the risk factors associated with poor outcomes of XDR-TB can help policy makers and organizations in the process of designing and implementing effective programs.
引用
收藏
页码:5429 / 5448
页数:20
相关论文
共 93 条
[1]  
Abilleira F, 2015, BIOMEDICA, V35, P285, DOI [10.1590/S0120-41572015000200017, 10.7705/biomedica.v35i2.2570]
[2]   Clinical outcomes in patients co-infected with COVID-19 and Staphylococcus aureus: a scoping review [J].
Adalbert, Jenna R. ;
Varshney, Karan ;
Tobin, Rachel ;
Pajaro, Rafael .
BMC INFECTIOUS DISEASES, 2021, 21 (01)
[3]   Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis [J].
Alemu, Ayinalem ;
Bitew, Zebenay Workneh ;
Worku, Teshager ;
Gamtesa, Dinka Fikadu ;
Alebel, Animut .
PLOS ONE, 2021, 16 (06)
[4]  
Amaral L, 2012, IN VIVO, V26, P231
[5]   PET/CT imaging of Mycobacterium tuberculosis infection [J].
Ankrah A.O. ;
van der Werf T.S. ;
de Vries E.F.J. ;
Dierckx R.A.J.O. ;
Sathekge M.M. ;
Glaudemans A.W.J.M. .
Clinical and Translational Imaging, 2016, 4 (2) :131-144
[6]   Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference? [J].
Balabanova, Yanina ;
Ignatyeva, Olga ;
Fiebig, Lena ;
Riekstina, Vija ;
Danilovits, Manfred ;
Jaama, Kadri ;
Davidaviciene, Edita ;
Radiulyte, Birute ;
Popa, Christina Marcela ;
Nikolayevskyy, Vladyslav ;
Drobniewski, Francis .
THORAX, 2016, 71 (09) :854-861
[7]   Survival of Civilian and Prisoner Drug-Sensitive, Multi- and Extensive Drug- Resistant Tuberculosis Cohorts Prospectively Followed in Russia [J].
Balabanova, Yanina ;
Nikolayevskyy, Vladyslav ;
Ignatyeva, Olga ;
Kontsevaya, Irina ;
Rutterford, Clare M. ;
Shakhmistova, Anastasiya ;
Malomanova, Nadezhda ;
Chinkova, Yulia ;
Mironova, Svetlana ;
Fedorin, Ivan ;
Drobniewski, Francis A. .
PLOS ONE, 2011, 6 (06)
[8]   Editorial: Bacterial pathogens, antibiotics and antibiotic resistance [J].
Banin, Ehud ;
Hughes, Diarmaid ;
Kuipers, Oscar P. .
FEMS MICROBIOLOGY REVIEWS, 2017, 41 (03) :450-452
[9]   Mortality and associated factors of patients with extensive drug-resistant tuberculosis: an emerging public health crisis in China [J].
Bei, Chengli ;
Fu, Manjiao ;
Zhang, Yao ;
Xie, Hebin ;
Yin, Ke ;
Liu, Yanke ;
Zhang, Li ;
Xie, Bangruan ;
Li, Fang ;
Huang, Hua ;
Liu, Yuhong ;
Yang, Li ;
Zhou, Jing .
BMC INFECTIOUS DISEASES, 2018, 18
[10]   Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000-2016 [J].
Bhering, Marcela ;
Duarte, Raquel ;
Kritski, Afranio .
PLOS ONE, 2019, 14 (11)